Dr. Hale is a pharmaceutical scientist/executive and global health social entrepreneur. She currently has a consulting business focused on global health and integrative medicine. She was founder and CEO of two successful nonprofit pharmaceutical companies, OneWorld Health (2000) and Medicines360 (2009). OneWorld Health was the first nonprofit pharmaceutical company in the U.S., focused on leishmaniasis, malaria, and cholera; Meds360 developed a hormonal IUD for contraception, approved by the FDA. She has raised $230M in philanthropic funding, primarily from the Bill & Melinda Gates Foundation. She has partnered with multiple global pharmaceutical companies for the discovery, manufacturing, and commercialization of global health products. She is a MacArthur Fellow, was inducted into the U.S. National Academy of Medicine, has been recognized as an outstanding global social entrepreneur by Skoll, Ashoka and Schwab Foundations. Her drug development experience was obtained at the FDA and Genentech, Inc. She earned her Ph.D. in Pharmaceutical Chemistry from University of California, San Francisco (UCSF), is presently Adjunct Professor of Bioengineering and Experimental Therapeutics, and was recently awarded Alumna of the Year, Graduate Division, UCSF. She lives in San Francisco and has raised two 20-somethings who are now out and about in the world.
